Modified chitosan derivative micelle system for natural anti-tumor product gambogic acid delivery

Drug Delivery

Volumn 16, Issue 7, 2009, Pages 363-370

  Qu, Guowei ^a,b   Zhu, Xian ^a   Zhang, Can ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Suzhou Municipal Hospital   (China)

Author keywords

Bile excretion

Indexed keywords

CHITOSAN DERIVATIVE; GAMBOGIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG HALF LIFE; MICELLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHITOSAN; DRUG DELIVERY SYSTEMS; FEMALE; MALE; MICE; MICELLES; RATS; RATS, SPRAGUE-DAWLEY; XANTHONES;

EID: 70449093381     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540903075545     Document Type: Article

References (43)

1. Aliabadi, H. M., and Lavasanifar, A. (2006). Polymeric micelles for drug delivery. Expert Opin Drug Deliv, 3, 139-162
2. Asano, J., Chiba, K., Tada, M., and Yoshii, T. (1996). Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry, 41, 815-820
3. Auterhoff, H., Frauendorf, H., Liesenklas, W., and Schwandt, C. (1962). The chief constituents of gamboge resins. 1. Chemistry of gamboge. Arch Pharm, 295, 833-846
4. Chandy, T., and Sharma, C. P. (1990). Chitosan-as a biomaterial. Biomat Art Cells Art Org, 18, 1-24.
5. Dai, J. G. (2003). The preparation of a kind of gambogic acid injection. CHN Patent CN 03131511.9.
6. Guo, Q. L., Lin, S. S., You, Q. D., Gu, H. Y., Yu, J., Zhao, L., Qi, Q., Liang, F., Tan, Z., and Wang, X. T. (2006a). Inhibition of human telomerase reverse transcriptase gene expression ganbogic acid in human hepatoma SMMC-7721 cells. Life Sci, 78, 1238-1245
7. Guo, Q. L., Qi, Q., You, Q. D., Gu, H. Y., Zhao, L., and Wu, Z. Q. (2006b). Toxicological studies of gambogic acid and its potential targets in experimental animals. Basic Clin Pharmacol Toxicol, 99, 178-184
8. Gupta, P. K., and Hung, C. T. (1989). Quantitative evaluation of targeted drug delivery systems. Int J Pharm, 56, 217-226
9. Hao, K., Liu, X. Q., Wang, G. J., and Zhao, X. P. (2007). Pharmacokinetics, tissue distribution and excretion of gambogic acid in rats. Eur J Drug Metab Pharmacokinet, 32, 63-68.
10. Hennenfent, K. L., and Govindan, R. (2005). Novel formulations of taxanes: a review. Old wine in a new bottle? Ann Oncol, 17, 735-749
11. Jin, B., Dong, H., and Qiao, L. (2003). The preparation of a kind of gambogic acid injection. CHN Patent CN 02124510.X.
12. Kasibhatla, S., Jessen, K. A., Maliartchouk, S., Wang, J. Y., English, N. M., Drewe, J., Qiu, L., Archer, S. P., Ponce, A. E., Sirisoma, N., Jiang, S., Zhang, H. Z., Gehlsen, K. R., Cai, S. X., Green, D. R., and Tseng, B. (2005). A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA, 102, 12095-12100
13. Kim, I. Y., Seo, S. J., Moon, H. S., Yoo, M. K., Park, I. Y., Kim, B. C., and Cho, C. S. (2008). Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv, 26, 1-21.
14. Kwon, G. S. (2003). Polymeric micelles for delivery of poorly water- soluble compounds. Crit Rev Ther Drug Carrier Syst, 20, 357-403.
15. Kwon, G. S., and Okano, T. (1996). Polymeric micelles as new drug carriers. Adv Drug Deliv Rev, 21, 107-116
16. Lin, L. J., Lin, L. Z., Pezzuto, J. M., Cordell, G. A., and Ruangrungsi, N. (1993). Isogambogic acid and isomorellinol from Garcinia hanburyi. Magn Reson Chem, 31, 340-347
17. Liu, W., Guo, Q. L., You, Q. D., Zhao, L., Gu, H. Y., and Yuan, S. T. (2005). Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J Gastroenterol, 11, 3655-3659
18. Maeda, H., Bharate, G. Y., and Daruwalla, J. (2009). Polymeric drugs for efficient tumor targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm, 71, 409-419
19. Mahmud, A., Xiong, X. B., Aliabadi, H. M., and Lavasanifar, A. (2007). Polymeric micelles for drug targeting. J Drug Target, 15, 553-584
20. Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., and Brem, H. (2007). Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf, 6, 609-621
21. Muzzarelli, R. A. A., and Muzzarelli, C. (2005). Chitosan chemistry: relevance to the biomedical sciences. Adv Polym Sci, 186, 151-209.
22. Narang, A. S., Delmarre, D., and Gao, D. (2007). Stable drug encapsulation in micelles and microemulsions. Int J Pharm, 345, 9-25.
23. Nishiyama, N., and Kataoka, K. (2006). Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery, Pharmacol Ther, 112, 630-648
24. Pandey, M. K., Sung, B., Ahn, K. S., Kunnumakkara, A. B., Chaturvedi, M. M., and Aggarwal, B. B. (2007). Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood, 110, 3517-3525
25. Patel, H. M. (1992). Serum opsonin and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Carrier Syst, 9, 39-90.
26. Qi, Q., You, Q. D., Gu, H. Y., Zhao, L., Liu, W., Lu, N., and Guo, Q. L. (2008). Studies on the toxicity of gambogic acid in rats. J Ethnopharmacol, 117, 433-438
27. Qu, G. W., Yao, Z., Zhang, C., Wu, X. L., and Ping, Q. N. (2009). PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Eur J Pharm Sci, 37, 98-105.
28. Torchilin, V. P. (2001). Structure and design of polymeric surfactantbased drug delivery systems. J Contr Rel, 73, 137-172
29. Varshosaz, J. (2007). The promise of chitosan microspheres in drug delivery systems. Expert Opin Drug Deliv, 4, 263-273
30. Wang, J., Mongayt, D., and Torchilin, V. P. (2005). Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target, 13, 73-80. (Pubitemid 40309464)
31. Wu, Z. Q., Guo, Q. L., You, Q. D., Zhao, L., and Gu, H. Y. (2004). Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull, 27, 1769-1774
32. Yao, Z., Zhang, C., Ping, Q. N., and Yu, L. (2007). A series of novel chitosan derivatives: synthesis, characterization and micellar solubilization of paclitaxel. Carbohyd Polym, 68, 781-792
33. Yasuhiro, M. (2008). Polymeric micellar delivery systems in oncology, Jpn J Clin Oncol, 38, 793-802.
34. You, Q. D., Guo, Q. L., Ke, X., Xiao, W., Dai, L. L., and Lin, Y. (2003). The preparations of gambogic acid and its compound. CHN Patent CN03132386.3.
35. Yu, J., Guo, Q. L., You, Q. D., Zhao, L., Gu, H. Y., Yang, Y., Zhang, H. W., Tan, Z., and Wang, X. (2007). Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis, 28, 632-638
36. Zhang, C., Ping, Q. N., Zhang, H. G., and Shen, J. (2003). Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol. Carbohyd Polym, 54, 137-141
37. Zhang, C., Qu, G. W., Sun, Y. J., Wu, X. L., Yao, Z., Guo, Q. L., Ding, Q. L., Yuan, S., Shen, Z. L., Ping, Q. N., and Zhou, H. P. (2008a). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials,29, 1233-1241
38. Zhang, C., Qu, G. W., Sun, Y. J., Yang, T., Yao, Z., Shen, W. B., Shen, Z. L., Ding, Q. L., Zhou, H. P., and Ping, Q. N. (2008b). Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur J Pharm Sci, 33, 415-423
39. Zhang, H. Z., Kasibhatla, S., Wang, Y., Herich, J., Guastella, J., Tseng, B., Drewe, J., and Cai, S. X. (2004). Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem Lett, 12, 309-317
40. Zhao, A. G. (2006). The preparation of a new kind of gambogic acid injection. CHN Patent CN 1857529.A.
41. Zhao, L., Guo, Q. L., You, Q. D., Wu, Z. Q., and Gu, H. Y. (2004). Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull, 27, 998-1003.
42. Zhou, Z. T., and Wang, J. W. (2007). Phase I human tolerability trail of gambogic acid. Chinese J New Drugs, 16, 79-83.
43. Zhu, X., Zhang, C., Wu, X. L., Tang, X. Y., and Ping, Q. N. (2008). Preparation, physical properties, and stability of gambogic acidloaded micelles based on chitosan derivatives. Drug Dev Ind Pharm, 34, 2-9.